knowledge -WSS

knowledge

author：comprehensive 2025-10-01 00:46:17 - browse：943

RHONA WISE/AFP via Getty Images

WASHINGTON — Drugmakers are doing everything to tap the bottomless well of demand for new obesity drugs, and they might get some government help. The agency that regulates Obamacare insurance is considering a technical change that would require insurers to cover obesity drugs in a market of more than 20 million Americans.

Weight loss drugs are a blessing for patients, a boon for drugmakers, and a potentially huge expense for insurers and taxpayers. Insurers have been slow to cover the drugs, called GLP-1 agonists, and without insurance, it costs upward of $16,000 annually for a drug that must be taken indefinitely.

There is a lot of demand for the drugs, but there are barriers to coverage. Medicare by law is prohibited from paying for obesity drugs. State Medicaid programs don’t have to cover them, so most don’t.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Eli Lilly’s Zepbound improved liver scarring in mid

leisure time

Wikipedia

WSS

Fight over Supreme Court dialysis ruling puts kidney patients at risk

An outdated Medicare rule harms dementia patients with anxiety

CMS got Medicare Advantage quality rating wrong, judge rules

FDA clears AI tool for detecting skin cancer

FTC loses bid to block Novant's North Carolina hospital merger

Novartis is flashing warning signs about its newly acquired myelofibrosis drug

explore

knowledge

Wikipedia

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

eGenesis tests gene

ChatGPT in medicine: STAT answers readers' burning questions

FDA clears AI tool for detecting skin cancer

Bright Health sells Medicare Advantage business to Molina

Copay coupons to count toward deductibles, after Biden court move

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

STAT wants to know your pick for a great summer read or listen

Medicare proposal to cover medical devices draws a mixed reaction

Anthony Fauci pushes back on GOP claims during Covid hearing

entertainment

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

Elevance PBM president out as customers face prescription chaos

New brain studies show LSD's effects on the brain in full color

Elevance PBM president out as customers face prescription chaos

Sutter Health’s antitrust win overturned by appeals court

Parkinson’s finding may lead to tests and, someday, treatments

hotspot

leisure time

Wikipedia

entertainment